RICONPHARMA LLC FDA Approval ANDA 214219

ANDA 214219

RICONPHARMA LLC

FDA Drug Application

Application #214219

Application Sponsors

ANDA 214219RICONPHARMA LLC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL0.125MG0TRIAZOLAMTRIAZOLAM
002TABLET;ORAL0.25MG0TRIAZOLAMTRIAZOLAM

FDA Submissions

UNKNOWN; ORIG1AP2020-10-20STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

RICONPHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214219
            [companyName] => RICONPHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRIAZOLAM","activeIngredients":"TRIAZOLAM","strength":"0.125MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TRIAZOLAM","activeIngredients":"TRIAZOLAM","strength":"0.25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/20\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"10\/22\/2020","submission":"SUPPL-1","supplementCategories":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-10-22
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.